MedPath
HSA Approval

PENOPEN 250 TABLET 250 mg

SIN01608P

PENOPEN 250 TABLET 250 mg

PENOPEN 250 TABLET 250 mg

June 1, 1988

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01CE02

phenoxymethylpenicillin

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD

Active Ingredients

PENICILLIN V POTASSIUM EQV PENICILLIN V

250 mg

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PENOPEN 250 TABLET 250 mg - HSA Approval | MedPath